Stock ALT ALTIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Altimmune, Inc.

Equities

ALT

US02155H2004

Market Closed - Nasdaq
Other stock markets
 04:00:01 2024-05-31 pm EDT 		5-day change 1st Jan Change
7.51 USD +6.98% Intraday chart for Altimmune, Inc. +2.46% -33.24%
May. 23 Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM
May. 09 Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress 2024
AQ
Shareholders that lost money on Altimmune, Inc.(ALT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
PR
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PR
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2024
AQ
Altimmune to Participate at Two Upcoming Investor Conferences
AQ
The Gross Law Firm Notifies Shareholders of Altimmune, Inc.(ALT) of a Class Action Lawsuit and an Upcoming Deadline
PR
ALT LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
NE
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
PR
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR
ALT INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
BU
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)
PR
The Gross Law Firm Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALT
PR
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
Robbins LLP Urges Altimmune, Inc. (ALT) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
BU
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALT Stock
  4. News Altimmune, Inc.
  5. Press Releases